Friday, 18 September 2026
09:30 – 10:00	Opening Ceremony
10:00 – 11:30	Plenary Session 1
	Chairs: Dr. Francisco Gómez Delgado, Dr. Serhat Ünal
10:00 – 10:40	Should Treatment Be Initiated with Combination Therapy in Newly Diagnosed Type 2 Diabetes? Insights from the VERIFY Study	Dr. Ozgur Demir
10:40 – 11:20	Diabetes mellitus and METABOLIC LIVER DISEASE	Dr. Francisco Gómez Delgado
11:20 – 11:50	COFFEE BREAK
11:50 – 12:30	Statins and the Development of Type 2 Diabetes Mellitus	Dr. Selcuk Yaylacı
12:30 -13:00	Discussion
13:00 – 14:30	LUNCH
14:30 – 15:50	Plenary Session 2
	Chairs: Dr. Kerim Güler, Dr. Dolores López Carmona
14:30 – 15:10	Practical Use of DPP-4 Inhibitors Through Clinical Cases	Dr. Ozgur Demir
15:10 – 15:50	Diabetes mellitus and PERIPHERAL ARTERIAL DISEASE	Dr. Dolores López Carmona
15:50 – 16:20	COFFEE BREAK
16:20 – 17:00	Are We Making Mistakes in the Clinical Use of DPP-4 Inhibitors?	Dr. Tufan Tükek
17:00 – 17:30	Discussion
17:30 – 18:30	Selected Abstract Presentations
Saturday, 19 September 2026
10:00 – 11:20	Plenary Session 3
	Chairs: Dr. Tufan Tükek, Dr. Alfredo Michán Doña
10:00 – 10:40	Diabetes mellitus and KIDNEY DISEASE	Dr. Alfredo Michán Doña
10:40 – 11:20	The Role of Calcium Channel Blockers in Hypertensive Patients with Diabetes	Dr. Tevfik Ecder
11:20 – 11:50	COFFEE BREAK
11:50 – 12:30	The Role of Calcium Channel Blockers in Diabetic Nephropathy	Dr. Tevfik Ecder
12:30 – 13:00	Discussion
13:00 – 14:30	LUNCH
14:30 – 15:50	Plenary Session 4
	Chairs: Dr. Gülistan Bahat Öztürk, Dr. Pablo Miramontes
14:30 – 15:10	Diabetes mellitus and SARCOPENIC OBESITY	Dr. Pablo Miramontes
15:10 – 15:50	Management of Type 2 Diabetes in Elderly Patients	Dr. Gülistan Bahat Öztürk
15:50 – 16:20	COFFEE BREAK
16:20 – 17:00	Case-Based Comprehensive Management of Type 2 Diabetes Mellitus	Dr. Uğur Can İzlimek
17:00 – 17:30	Discussion
17:30 – 18:30	Selected Abstract Presentations
18:30 – 19:00	Wrap up the meeting & Closing